Actively Recruiting
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
Led by Channel Medsystems · Updated on 2025-12-16
300
Participants Needed
2
Research Sites
238 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
CONDITIONS
Official Title
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled for a Cerene treatment
- 25 years of age and older
- Provided informed consent to participate in the registry
- English speaking
- Agrees to complete a survey at specified time points from baseline to 12 Months
You will not qualify if you...
- Physician discretion
- Vulnerable populations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Axia Women's Health / Rubino OB/GYN Group
West Orange, New Jersey, United States, 07052
Actively Recruiting
2
Seven Hills Women's Health Centers
Cincinnati, Ohio, United States, 45255
Actively Recruiting
Research Team
G
Gerard Reilly, MD
CONTACT
B
Brigette L. Tillman, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here